Skip to main content
EBS logo

EBS · Emergent BioSolutions Inc. · Proposed Sales

Track EBS — free
$5.79 -0.10 (-1.70%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$297.69M
Shares
51.42M
Volume · Nov 13 787.19K Avg daily vol (3M) 1.13M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-10-07 DONALD DEGOLYER 17,800
2026-10-01 PAUL WILLIAMS 3,000
2026-07-01 PAUL WILLIAMS 3,000
2026-05-01 SUJATA TYAGI DAYAL 13,761
2026-05-01 DONALD DEGOLYER 15,481
2026-05-01 KATHRYN ZOON 17,202
2026-04-30 KEITH KATKIN 15,481
2026-04-01 PAUL WILLIAMS 4,000
2026-01-07 LOUIS W SULLIVAN 25,748
2025-12-22 LOUIS W SULLIVAN 104,695
2025-12-05 RONALD RICHARD 32,848
2025-11-10 DONALD DEGOLYER 17,801
2025-11-07 SUJATA TYAGI DAYAL 8,552
2025-10-07 COLEEN GLESSNER 30,608
2025-08-15 KATHRYN ZOON 7,086
2025-08-12 DONALD DEGOLYER 7,844
2025-05-23 KEITH KATKIN 7,844
2025-03-12 Zoon Kathryn C 10,000
2025-03-12 Fowler Neal Franklin 35,000
2024-11-12 White Marvin L 14,287
2024-11-12 DeGolyer Donald W 25,000
2024-06-04 Zoon Kathryn C 10,000
Showing 1–22 of 22 filings
Key facts CIK 1367644 CUSIP 29089Q105 13F (30d) 142 filings 122 filers Visit website Investor relations